T. Rowe Price Associates »

Inovio Pharmaceuticals shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Inovio Pharmaceuticals (INO) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Inovio Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Inovio Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inovio Pharmaceuticals by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $77k 150k 0.51

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Nvidia Corporation Comm Stk (NVDA)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Intuit Comm Stk (INTU)
Servicenow Comm Stk (NOW)
Fiserv Comm Stk (FI)

View all positions for T. Rowe Price Associates

Top funds holding Inovio Pharmaceuticals

T. Rowe Price Associates
Tudor Investment Corporation
Green Alpha Advisors
Cedar Brook Financial Partners
Farther Finance Advisors
Simplex Trading
EverSource Wealth Advisors
Cornerstone Planning Group
Valley National Advisers
Advisory Services Network
Newbridge Financial Services Group
American National Bank
City State Bank
AdvisorNet Financial
Hanson McClain Advisors

View all funds holding Inovio Pharmaceuticals